Role of microRNAs in the regulation of RKIP and signaling pathways in cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2025.189508 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Graziana Spoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Phosphatidylethanolamine Binding Protein, Neoplasms. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero dell'Istruzione dell'Università e della Ricerca.
Abstract (Originalsprache)
Raf kinase inhibitor protein (RKIP), also known as Phosphatidyl Ethanolamine Binding Protein (PEBP1), is a pivotal modulator of multiple intracellular signaling cascades involved in tumorigenesis, progression, metastasis, and cancer therapy resistance. In recent years, increasing evidence has highlighted the regulatory role of non-coding RNAs, particularly microRNAs (miRNAs), in modulating RKIP expression and activity across various types of cancer. This review aims to comprehensively summarize current knowledge on the post-transcriptional regulation of RKIP by miRNAs, elucidating their impact on tumor biology. For this purpose, a systematic analysis of published experimental studies was conducted, focusing on both solid and hematological malignancies. The review discusses how miRNAs, such as miR-23a, miR-27a, miR-224, miR-181a, and others, directly or indirectly suppress RKIP, contributing to enhanced proliferation, invasion, epithelial-mesenchymal transition (EMT), cancer stem cell (CSC) traits, and radioresistance. Additionally, long non-coding RNAs (lncRNAs) like XIST and PEBP1P2 were identified as factors able to modulate RKIP suppression by acting as molecular sponges for miRNAs or stabilizing RKIP transcripts. All the data presented in the manuscript are supported by diverse experimental approaches, including transcriptional analyses, functional in vitro assays (migration, invasion, apoptosis), gain- and loss-of-function experiments, luciferase reporter assays, and in vivo xenograft models, further validating the miRNA-RKIP axis involved in the progression of multiple tumors. In conclusion, this review provides an integrated view of the complex post-transcriptional network governing RKIP regulation in cancer, underscoring the potential of targeting RKIP-associated non-coding RNA axes for innovative therapeutic strategies aimed at halting tumor progression and overcoming treatment resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy. Electr…
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy. Electronic address: luca.falzone@unict.it.
Förderung
- European Commission
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero dell'Istruzione dell'Università e della Ricerca
- University of Catania
Zitieren
APA
Spoto, G., Libra, M., & Falzone, L. (2026). Role of microRNAs in the regulation of RKIP and signaling pathways in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189508
Vancouver
Spoto G, Libra M, Falzone L. Role of microRNAs in the regulation of RKIP and signaling pathways in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189508
BibTeX
@article{Spoto2026,
author = {Spoto, Graziana and Libra, Massimo and Falzone, Luca},
title = {Role of microRNAs in the regulation of RKIP and signaling pathways in cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2025.189508}
}
EUVIMED